Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the Price/OCF ratio high or low?
The Price/OCF ratio of 30.01 is 66% below its estimated 1-year average of 89.01, near the low end of its estimated 1-year range (30.01–99.69).
As of 2026-10-06T15:42:35.507Z.
Calculation as of: 2026-10-06T15:42:35.507Z.
Quote observation: 2026-10-06T15:40:32.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 295890ca45b9fb7c845dc9b7cfc12ce3e82df22f7cd737cbd4420fef5fb5231a
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/OCF RATIO
30.01
PRICE/OCF RATIO AVG TTM
N/A
PRICE/OCF RATIO AVG 3Y
N/A
PRICE/OCF RATIO AVG 5Y
N/A
PRICE/OCF RATIO AVG 10Y
N/A
PRICE/OCF RATIO AVG 15Y
N/A
PRICE/OCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
16.79
median of 204 covered companies
CURRENT VS SECTOR MEDIAN
+78.74%
vs the sector median at left
Market Cap
$2.38B
Price/OCF Ratio
N/A
TTM Avg
54.75
3Y Avg
54.75
5Y Avg
54.75
Market Cap
$2.38B
Price/OCF Ratio
17.44
TTM Avg
42.28
3Y Avg
63.13
5Y Avg
63.13
Market Cap
$2.40B
Price/OCF Ratio
31.18
TTM Avg
37.03
3Y Avg
38.41
5Y Avg
35.77
Market Cap
$2.32B
Price/OCF Ratio
6.54
TTM Avg
6.21
3Y Avg
8.19
5Y Avg
14.19
Market Cap
$2.44B
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.29B
Price/OCF Ratio
N/A
TTM Avg
35.55
3Y Avg
17.39
5Y Avg
17.83
| NAME | MARKET CAP | PRICE/OCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Liquidia Corporation (LQDA) | $2.37B | 30.01 | N/A | N/A | N/A |
| Nurix Therapeutics, Inc. (NRIX)vs › | $2.38B | N/A | 54.75 | 54.75 | 54.75 |
| ADMA Biologics, Inc. (ADMA)vs › | $2.38B | 17.44 | 42.28 | 63.13 | 63.13 |
| Clover Health Investments, Corp. (CLOV)vs › | $2.40B | 31.18 | 37.03 | 38.41 | 35.77 |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.42B | N/A | N/A | N/A | N/A |
| Harmony Biosciences Holdings, Inc. (HRMY)vs › | $2.32B | 6.54 | 6.21 | 8.19 | 14.19 |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.44B | N/A | N/A | N/A | N/A |
| Maravai LifeSciences Holdings, Inc. (MRVI)vs › | $2.29B | N/A | 35.55 | 17.39 | 17.83 |
| Disc Medicine, Inc. (IRON)vs › | $2.46B | N/A | N/A | N/A | N/A |
| Pharvaris N.V. (PHVS)vs › | $2.16B | N/A | N/A | N/A | N/A |
P/OCF Ratio
30.0
P/FCF Ratio
39.2
P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PRICE/OCF RATIO |
|---|---|
| 2026-10-05 | 35.46 |
| 2026-10-02 | 36.74 |
| 2026-10-01 | 35.91 |
| 2026-09-30 | 38.82 |
| 2026-09-29 | 90.69 |
| 2026-09-28 | 94.52 |
| 2026-09-25 | 87.79 |
| 2026-09-24 | 91.03 |
| 2026-09-23 | 86.59 |
| 2026-09-22 | 88.06 |
| 2026-09-21 | 85.23 |
| 2026-09-18 | 85.81 |
| 2026-09-17 | 87.74 |
| 2026-09-16 | 87.82 |
| 2026-09-15 | 84.32 |
| 2026-09-14 | 83.79 |
| 2026-09-11 | 85.63 |
| 2026-09-10 | 87.05 |
| 2026-09-09 | 88.68 |
| 2026-09-08 | 86.83 |
| 2026-09-04 | 88.09 |
| 2026-09-03 | 88.05 |
| 2026-09-02 | 89.40 |
| 2026-09-01 | 85.84 |
| 2026-08-31 | 87.46 |
| 2026-08-28 | 86.85 |
| 2026-08-27 | 89.73 |
| 2026-08-26 | 91.55 |
| 2026-08-25 | 90.44 |
| 2026-08-24 | 90.16 |
| 2026-08-21 | 88.04 |
| 2026-08-20 | 91.16 |
| 2026-08-19 | 96.65 |
| 2026-08-18 | 95.36 |
| 2026-08-17 | 99.69 |
| 2026-08-14 | 95.51 |
| 2026-08-13 | 92.50 |
